February 14th Deadline in Lawsuit for Investors in Abeona Therapeutics Inc (NASDAQ:ABEO) shares announced by Shareholders Foundation

SAN DIEGO, CA /
ACCESSWIRE / February 6, 2017 / The Shareholders Foundation, Inc. announces that a lawsuit was filed in New York for certain purchasers of NASDAQ:ABEO shares against The Abeona Therapeutics Inc over alleged Securities Laws Violations.

Investors who purchased shares of Abeona Therapeutics Inc (NASDAQ: ABEO) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

On December 12, 2016, a report was published on Abeona Therapeutics Inc asserting, among other things, that Abeona Therapeutics Inc’s “science is demonstrably unviable with numerous irrefutable flaws that will lead to failure”. The report also alleged that Steven H. Rouhandeh, Abeona Therapeutics’ Executive Chairman and Principal Executive Officer, was a former managing director at D. Blech & Co. brokerage firm, which was the subject of a SEC investigation in the 1990s, and a securities class action that reached $15 million settlement for investors, based on allegations that D. Blech & Co artificially manipulated the price of various biotech stocks and maintained the market price of the biotech stocks to keep its company’s interest in the stocks afloat.

On December 16, 2016, a lawsuit was filed against Abeona Therapeutics Inc over alleged securities laws violations. The plaintiff claims that the defendants made false and/or misleading statements and/or failed to disclose that the science behind Abeona’s proposed gene therapy treatment for Sanfilippo syndrome is unviable, that Steven H. Rouhandeh, Abeona Therapeutics, Inc’s Executive Chairman and Principal Executive Officer, previously worked in a high ranking position for a biotech promoter who was convicted of securities fraud and involved in manipulating biotech stocks, and that as a result, defendants’ statements about Abeona Therapeutics, Inc’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Those who purchased Abeona Therapeutics Inc (NASDAQ: ABEO) shares should contact the Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

CONTACT:

Shareholders Foundation, Inc.

Michael Daniels

+1 (858) 779-1554

mail@shareholdersfoundation.com

3111 Camino Del Rio North

Suite 423

San Diego, CA 92108

SOURCE: Shareholders Foundation, Inc.

ReleaseID: 454328